Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 406Uterine Cervical Neoplasms 400Endometrial Neoplasms 197Carcinoma, Ovarian Epithelial 100Breast Neoplasms 72Fallopian Tube Neoplasms 71Uterine Cervical Dysplasia 68Neoplasms 51Colorectal Neoplasms 42Pancreatic Neoplasms 40Stomach Neoplasms 39Peritoneal Neoplasms 32Papillomavirus Infections 32Recurrence 31Uterine Neoplasms 29Vulvar Neoplasms 27Prostatic Neoplasms 26Lung Neoplasms 24Esophageal Neoplasms 23Urinary Bladder Neoplasms 22Melanoma 20Colonic Neoplasms 20Head and Neck Neoplasms 19Gynecologic Cancer 19Endometrial Hyperplasia 18Neoplasm Metastasis 17Carcinoma, Non-Small-Cell Lung 17Squamous Intraepithelial Lesions 16Sarcoma 16Ovarian Cysts 15

Interventions

olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hyperglycemia × Gynecologic × Clear all
NCT05081765 2021-10-18

The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib

Poznan University of Medical Sciences

Unknown
40 enrolled
Gynecologic

Hyperglycemia, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡